Aegirbio AB (publ) Revenue and Competitors
Estimated Revenue & Valuation
- Aegirbio AB (publ)'s estimated annual revenue is currently $2.3M per year.
- Aegirbio AB (publ)'s estimated revenue per employee is $155,000
Employee Data
- Aegirbio AB (publ) has 15 Employees.
- Aegirbio AB (publ) grew their employee count by 0% last year.
Aegirbio AB (publ)'s People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | CFO | Reveal Email/Phone |
Aegirbio AB (publ) Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $2.8M | 18 | -33% | N/A | N/A |
#10 | $9.1M | 59 | -9% | N/A | N/A |
What Is Aegirbio AB (publ)?
Aegirbio, envision a future where nearly everyone could easily and continuously monitor health issues by promoting the development of novel diagnostics. Aegirbio aims to increase the supply and sophistication of diagnostic technologies, including the ability to differentiate between diseases that present with similar symptoms, identify the presence of latent infectious agents, and provide practical low-cost monitoring for treatment efficacy and disease recurrence. Aegirbio’s ambition is, in addition to bringing to market innovative diagnostic technologies, to make diagnostics: more accessible, easier to use, give accurate and easy transferable results.
keywords:N/AN/A
Total Funding
15
Number of Employees
$2.3M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.3M | 15 | N/A | N/A |
#2 | $1.3M | 15 | N/A | N/A |
#3 | $1.3M | 15 | N/A | N/A |
#4 | $1.3M | 15 | N/A | N/A |
#5 | $1.8M | 15 | N/A | N/A |